If you are not ensuring complete elimination of contaminating bacteria there will always be the risk of transfusion transmitted bacterial infection through platelet components and the chance of a septic transfusion reaction. Given that transfusion transmitted bacterial infection and septic transfusion reaction remain the principle causes of mortality related to transfusion, we thought it is our duty to address this blood safety risk in greater depth.
The information on this site is not country-specific, and may contain information that is outside the approved indications for the country in which you are located. Use of INTERCEPT Plasma or Platelets is contraindicated in patients with a history or allergic response to amotosalen or psoralens. Consult instructions for use for indications, contraindications, warnings, and precautions.
Cerus, INTERCEPT and the Cerus logo are trademarks of Cerus Corporation.